MorphoSys AG
F:MOR2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MorphoSys AG
F:MOR2
|
DE |
|
B
|
Bilibili Inc
SWB:71BA
|
CN |
|
Block Energy PLC
F:BE9
|
UK |
|
MorphoSys AG
F:MOR
|
DE |
|
P
|
Pineapple Power Corporation PLC
F:8JZ
|
UK |
|
F
|
FutureFuel Corp
F:3FF
|
US |
|
G
|
Genesis AI Corp
CNSX:AIG
|
CA |
|
T
|
Teladoc Health Inc
F:4LL
|
US |
|
B
|
Bilibili Inc
F:71BA
|
CN |
|
N
|
Nordstrom Inc
XMUN:NRD
|
US |
|
F
|
Farmer Bros Co
F:FB1
|
US |
|
M
|
McDonald's Corp
F:MDO
|
US |
|
Ames National Corp
NASDAQ:ATLO
|
US |
|
W
|
Williams Companies Inc
XMUN:WMB
|
US |
|
A
|
Acea SpA
XMUN:DCA
|
IT |
|
Endeavour Mining PLC
F:6E2
|
UK |
|
A
|
Astra International Tbk PT
XMUN:ASJA
|
ID |
|
Banco Comercial Portugues SA
ELI:BCP
|
PT |
|
LuxExperience BV
F:0FV
|
DE |
|
N
|
Nordstrom Inc
XBER:NRD
|
US |
|
Albertsons Companies Inc
F:27S
|
US |
|
Immunitybio Inc
NASDAQ:IBRX
|
US |
|
P
|
Poolbeg Pharma PLC
OTC:POLBF
|
UK |
|
XPS Pensions Group PLC
F:406
|
UK |
Bankruptcy Probability
MorphoSys AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
MorphoSys AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
MorphoSys AG
XETRA:MOR
|
2.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
MorphoSys AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, MorphoSys AG has total debt of 255.2m EUR. This includes both short-term (0 EUR) and long-term (255.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
